OCGN 1.12 (+0%)
US67577C1053BiotechnologyBiotechnology

Ocugen (OCGN) Financial Metrics

This table shows a selected set of financial data points of Ocugen (OCGN). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 -0.26 0 -2.21 139.27M -0.73 6.04M -72.53M -64.83M -63.08M 39.46M
2022 -0.4 0 -3.21 278.98M -0.81 2.49M -64.54M -88.59M -86.8M 77.56M
2021 -0.3 0 -15.2 887.31M -0.88 22.92K -48.88M -57.8M -58.37M 94.96M
2020 -0.19 0 -9.41 205.39M -0.99 43K -15.02M -14M -21.82M 24.04M
2019 -1.46 0 -0.36 7.22M -1.18 0 -16.92M -14.89M -20.24M 7.44M
2018 -13.98 0 -0.38 3.26M -0.61 0 -17.79M -8.19M -8.64M 15.54M
2017 -69.91 0 -1.76 46.47M -1.12 0 -23.3M -24.88M -26.41M 7.08M
2016 -67.58 0 -1.48 24.03M -0.44 0 -26.06M -14.54M -16.21M 31.91M
2015 -145.22 0 -1.45 46.31M -0.63 0 -31.98M -30.41M -32.02M 30.92M
2014 -891.47 0 -0.74 16.87M -0.57 0 -21.73M -22.07M -22.79M 58.06M
2013 -120.93 0 0 0 -1.43 8K -15.89M -25.15M -25.71M 8.73M
2012 -79.65 0 0 0 0 26K -12.31M -16.3M -16.94M 14.72M

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.